1 Min Read
Jan 5 (Reuters) - Adocia SA :
* Adocia announces two new multi-hormonal combination projects for the treatment of type 1 diabetes
* Medical benefit of such combinations already established in type 1 diabetes clinical trials with separate injections
* First clinical study expected to start in Q4 2017.
* New projects aim to offer more efficient therapy to people living with type 1 diabetes without increasing number of injections.
* Biochaperone enables combinations of insulin lispro with pramlintide and insulin lispro with exenatide, three hormones approved for treatment of diabetes Source text for Eikon: Further company coverage: (Gdynia Newsroom)